Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - disodium copper edta - unknown - disodium copper edta active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - disodium cobalt edta - unknown - disodium cobalt edta mineral-cobalt active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - disodium zinc edta - unknown - disodium zinc edta active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - disodium cobalt edta - unknown - disodium cobalt edta mineral-cobalt active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - disodium copper edta - unknown - disodium copper edta active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - disodium manganese edta (manganese) - unknown - disodium manganese edta (manganese) chelating agent active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - disodium zinc edta - unknown - disodium zinc edta active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

australian pesticides and veterinary medicines authority - disodium zinc edta - unknown - disodium zinc edta active 0.0 - active constituent

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

snap medical industries - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - adrenalin ® is available as a single-use 1 ml vial and a multiple-use 30 ml vial for intramuscular and subcutaneous use. emergency treatment of allergic reactions (type i), including anaphylaxis, which may result from allergic reactions to insect stings, biting insects, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. the signs and symptoms associated with anaphylaxis include flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with hypotension, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, airway swelling, laryngospasm, bronchospasm, pruritus, urticaria or angioedema, swelling of the eyelids, lips, and tongue. indicated for patients weighing greater than or equal to 15kg (33 lbs) none. teratogenic effects: pregnancy category c. there are no adequate and well-controlled studies in pregnant women. epinephrine should be used during pregnancy only if the pote

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

cd acquisitions, llc - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - adrenalin® is available as a single-use 1 ml vial for intramuscular and subcutaneous use. emergency treatment of allergic reactions (type i), including anaphylaxis, which may result from allergic reactions to insect stings, biting insects, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. the signs and symptoms associated with anaphylaxis include flushing, apprehension, syncope, tachycardia, thready or unobtainable pulse associated with hypotension, convulsions, vomiting, diarrhea and abdominal cramps, involuntary voiding, airway swelling, laryngospasm, bronchospasm, pruritus, urticaria or angioedema, swelling of the eyelids, lips, and tongue. none. 8.1 pregnancy teratogenic effects: pregnancy category c. there are no adequate and well-controlled studies in pregnant women. epinephrine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus (fetal anoxia, spontaneous abortion, or both). epinephrine is teratogenic in rabbits, mice and hamsters dosed during organogenesis. epinephrine has been shown to have teratogenic effects (including gastroschisis and embryonic lethality) when administered subcutaneous in rabbits at approximately 15 times the maximum recommended intramuscular or subcutaneous dose (on a mg/m2 basis at a maternal subcutaneous dose of 1.2 mg/kg/day for two to three days). in mice, teratogenic effects (including embryonic lethality) were observed at approximately 3 times the maximum recommended intramuscular or subcutaneous dose (on a mg/m2 basis at maternal subcutaneous dose of 1 mg/kg/day for 10 days). these effects were not seen in mice at approximately 2 times the maximum recommended daily intramuscular or subcutaneous dose (on a mg/m2 basis at a subcutaneous maternal dose of 0.5 mg/kg/day for 10 days). in hamsters, teratogenic effects were observed at approximately 2 times the maximum recommended intramuscular or subcutaneous dose (on a mg/m2 basis at a maternal subcutaneous dose of 0.5 mg/kg/day for 4 days). 8.2 labor and delivery use with caution during labor and delivery. although epinephrine improves maternal hypotension associated with anaphylaxis, it may result in uterine vasoconstriction, decreased uterine blood flow, and fetal anoxia. 8.3 nursing mothers it is not known whether epinephrine is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when epinephrine is administered to a nursing woman. 8.4 pediatric use clinical use data support weight-based dosing for treatment of anaphylaxis in pediatric patients, and other reported clinical experience with the use of epinephrine suggests that the adverse reactions seen in children are similar in nature and extent to those both expected and reported in adults. 8.5 geriatric use clinical studies for the treatment of anaphylaxis have not been performed in subjects aged 65 and over to determine whether they respond differently from younger subjects. however, other reported clinical experience with use of epinephrine for the treatment of anaphylaxis has identified that geriatric patients may be particularly sensitive to the effects of epinephrine. therefore, for the treatment of anaphylaxis, consider starting with a lower dose to take into account potential concomitant disease or other drug therapy.